http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3860605-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4783407e23a20dbe43d383a5d0fcb5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8719f1359aed6ee3805fbd6bc4a2a4bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f029afd11ac7df1ce36b9e88f2beb6de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_158593f71452bb11a6d91fe555d02656
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b79b4de61f5cda603ad7b03f4924d528
publicationDate 2021-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3860605-A1
titleOfInvention Crystalline forms and processes of lenvatinib besylate
abstract The present invention relates to lenvatinib besylate, its crystalline forms and processes for making them. Furthermore, to a pharmaceutical composition comprising a therapeutically effective dose of lenvatinib besylate.
priorityDate 2018-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23623894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230368412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67512735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16718439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234397312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228807413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15544966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823820
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227134592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394485

Total number of triples: 54.